Blood type’s influence extends far beyond compatibility for blood donations, affecting the body through multiple biological ...

Q1 2025 Earnings Call Transcript May 6, 2025 Dynavax Technologies Corporation misses on earnings expectations. Reported EPS is $0.01 EPS, expectations were $0.03. Operator: Good day ladies and ...

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

Anti-Aβ antibodies (Aβ-Abs) that bind specific Aβ variants are essential research tools. Furthermore, the monoclonal Aβ-Abs Aducanumab, Lecanemab, and Donanemab have recently gained approval as the ...

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with ...

Hamid’s central claim is that the Basic Structure Doctrine (BSD) is a foreign doctrine, adopted wholesale from the Indians, with no link whatsoever to the Malaysian Constitution. This is a grave ...

Partnership Combines VERAXA's Proprietary ADC Technology with OmniAb's Antibody Discovery Technology for Novel Therapies Targeting Solid TumorsZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG ...

Tovecimig (DLL4 x VEGF-A bispecific antibody) met the primary endpoint in the ongoing randomized Phase 2/3 Study in patients with biliary tract cancer (BTC). Achieved a 17.1% overall response rate ...

If you've been hopping between arms for booster shots, a new study suggests that your lymph nodes remember exactly where you ...

Avanos Medical, Inc. today reported first quarter 2025 financial results. "In my first couple of weeks at Avanos, I've noticed ...

Cohort B results from the ASCEND trial accepted for an oral presentation at ESMO-GI 2025 BASKING RIDGE, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata” or the ...